BCY-10611-56811
4 vaccinations
10 coded responses
34 check-ins
10 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 601 / IL
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-03
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-05
-
2021-04-06
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
-
2021-04-28
Dose 2 — Pfizer-BioNTech
-
2021-05-02
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Injection bruising 8 days laterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Brushing at the injection site persists 9 days laterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Persistent bruising at the injection site - not worsening but not improving.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — day 7, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Persistent bruising at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-07-28
-
2021-10-27
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Full COVID symptoms including loss of taste and smell. No prolonged feverMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-02
-
2021-12-15
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-04-28
-
2022-04-29
Dose 4 — Pfizer-BioNTech
-
2022-05-02
Survey response — days 1–6 daily, dose 4MedDRA: Injection site bruising — Feeling: Good · Site: Pain · Joint painsFree text: Injection site bruisedMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Survey response — days 1–6 daily, dose 4MedDRA: Injection site bruising, Injection site pain — Feeling: GoodFree text: Bruise at injection site is sore and grew to approximately the size of a quarter.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-04
-
2022-05-05
Survey response — days 1–6 daily, dose 4MedDRA: Injection site bruising — Feeling: GoodFree text: Still bruised at the injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-05-07
- 2022-05-14
- 2022-05-21
- 2022-05-27
- 2022-06-03
- 2022-06-10
- 2022-07-31
- 2022-10-30
- 2023-04-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): None
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): None
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Injection bruising 8 days later
Systemic reaction (other): Brushing at the injection site persists 9 days later
Systemic reaction (other): Persistent bruising at the injection site - not worsening but not improving.
Release 8 — day 7, dose 2
Systemic reaction (other): Persistent bruising at the injection site
Release 10 — 6 months, dose 2
Symptoms: Full COVID symptoms including loss of taste and smell. No prolonged fever
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Injection site bruised
Systemic reaction (other): Bruise at injection site is sore and grew to approximately the size of a quarter.
Systemic reaction (other): Still bruised at the injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release